Pharmaceutical Alliances

Pharmaceutical Alliances The requirement for the assignment is that it should be a total of 1200 words or more. There is a total of 4 questions (so you could do 300 words per question or whatever works). The questions are self explanatory. There are two pictures that consist of the case study and you may have to zoom in but they should be okay to read. Here they are:1. In a narrative format, discuss the key facts and critical issues presented in the case.2. What do you think are the possible major tensions that exist when a pharmaceutical firm forms an alliance with a biotechnology firm? How would you try to address those tensions?3. Identify different challenges that exist for maintaining or strengthening an ongoing alliance versus beginning a new relationship. Should this alliance occur? Why or why not?4. If you were a CEO of one of the organizations, what steps would you take to foster relationships?(There is not a certain number of pages that I have to have it is the word count that has to be met which is 1200) Answer Preview……………..Question 1. Accor

💡 Buy the answer for only $12 Get it now →

ding to the case presented, there has been a significant increase in the appeal of pharmaceutical and biotechnology companies’ collaboration for efficiency in achieving organizational objectives. Statistics indicate a tripling of the revenues of the companies that have in the past been involved in the alliances since, despite the consistencies in the rate of alliance formation over the past few years, the value of the companies has tripled within the same time. Consequently, this alludes to the significant benefits associated with these alliances, which have improved the perception among the people in within the industry. According to research, the benefits that companies involved in such alliance efforts are always greater than the challenges, which invests in such business relationships beneficial to the partners involved. However, the case also notes that most of the recorded alliances between 2004 and 2009 involved companies in the pharmaceutical industry merging with those in the biotech industry……………………APA 1267 words
$16.00 – Purchase Checkout

💡 Buy the answer for only $12 Get it now →